KemPharm, Inc.
(NASDAQ : KMPH)

( )
KMPH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 1.15%27.7514.1%$163.28m
RVMDRevolution Medicines, Inc. -2.04%28.310.0%$120.04m
AMRNAmarin Corp. Plc -0.40%17.621.7%$106.11m
CTLTCatalent, Inc. 1.43%60.452.2%$71.17m
GWPHGW Pharmaceuticals Plc 0.76%127.106.2%$67.15m
JAZZJazz Pharmaceuticals Plc -0.76%140.852.3%$59.43m
AXSMAxsome Therapeutics, Inc. 2.03%90.471.9%$54.45m
ICPTIntercept Pharmaceuticals, Inc. 0.16%94.8416.9%$49.24m
UTHRUnited Therapeutics Corp. 0.19%104.1914.3%$48.27m
HZNPHorizon Therapeutics Plc 0.25%35.936.6%$47.54m
SAGESAGE Therapeutics, Inc. 0.06%68.088.6%$45.35m
PRGOPerrigo Co. Plc -0.36%57.756.8%$44.68m
ZGNXZogenix, Inc. -0.22%32.189.4%$43.34m
MNKMallinckrodt Plc -8.72%4.5020.9%$40.50m
ENDPEndo International Plc -0.81%6.158.8%$39.71m

Company Profile

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.